Mortality in a nationwide practice-based cohort receiving paclitaxel-coated devices for lower limb peripheral artery disease
M Wargny, C Leux, G Chatellier, S Coudol… - Journal of the American …, 2024 - jacc.org
Background According to a meta-analysis of randomized clinical trials, paclitaxel-coated
devices (PCDs) for lower limb endovascular revascularization may be associated with …
devices (PCDs) for lower limb endovascular revascularization may be associated with …
Survival and causes of death among veterans with lower extremity revascularization with paclitaxel‐coated devices: insights from the veterans health administration
JA Gutierrez, SV Rao, WS Jones… - Journal of the …, 2021 - Am Heart Assoc
BACKGROUND The long‐term safety of paclitaxel‐coated devices (PCDs; drug‐coated
balloon or drug‐eluting stent) for peripheral endovascular intervention is uncertain. We used …
balloon or drug‐eluting stent) for peripheral endovascular intervention is uncertain. We used …
Mortality with paclitaxel-coated devices in peripheral artery disease
J Nordanstig, S James, M Andersson… - … England Journal of …, 2020 - Mass Medical Soc
Background The results of a recent meta-analysis aroused concern about an increased risk
of death associated with the use of paclitaxel-coated angioplasty balloons and stents in …
of death associated with the use of paclitaxel-coated angioplasty balloons and stents in …
Mortality is not associated with paclitaxel-coated devices usage in peripheral arterial disease of lower extremities
DS Ko, GH Bae, ST Choi, J Jung, JM Kang - Scientific Reports, 2021 - nature.com
A recent meta-analysis addressed increased risk of death following revascularization with
paclitaxel-coated devices in femopopliteal artery. We evaluated differences in all-cause …
paclitaxel-coated devices in femopopliteal artery. We evaluated differences in all-cause …
[HTML][HTML] Long-term safety of drug-coated devices for peripheral revascularisation: Long-term safety of peripheral drug-coated devices
EA Secemsky, E Barrette, L Bockstedt, M Bonaca… - …, 2021 - ncbi.nlm.nih.gov
Background Meta-analyses of randomised trials of paclitaxel-coated peripheral devices
found an association with worse long-term survival. Aims We aimed to assess long-term …
found an association with worse long-term survival. Aims We aimed to assess long-term …
Editor's Choice–Real World Study of Mortality After the Use of Paclitaxel Coated Devices in Peripheral Vascular Intervention
Objective This observational cohort study examined outcomes after peripheral vascular
intervention (PVI) with paclitaxel coated devices (PCD) and non-PCD, and evaluated …
intervention (PVI) with paclitaxel coated devices (PCD) and non-PCD, and evaluated …
The safety of paclitaxel-coated devices for patients with peripheral artery disease
AK Krawisz, EA Secemsky - Current cardiology reports, 2021 - Springer
Abstract Purpose of Review Peripheral artery disease (PAD) is a common, debilitating
disease that impacts 8.5 million Americans and carries a poor prognosis. The most common …
disease that impacts 8.5 million Americans and carries a poor prognosis. The most common …
Late Mortality and Paclitaxel-Coated Devices: Has the Controversy Finally Come to an End?
A Raja, EA Secemsky - Journal of the Society for Cardiovascular …, 2023 - jscai.org
Advances in technology have led to the emergence of endovascular therapy as a primary
treatment option for patients with peripheral artery disease (PAD), with the goal of improving …
treatment option for patients with peripheral artery disease (PAD), with the goal of improving …
Sex disparities in long-term mortality after paclitaxel exposure in patients with peripheral artery disease: a nationwide claims-based cohort study
Background: Randomized controlled trials have reported excess mortality in patients treated
with paclitaxel-coated devices versus uncoated devices, while observational studies have …
with paclitaxel-coated devices versus uncoated devices, while observational studies have …
Systematic review and meta-analysis of the outcomes of drug-eluting stent versus drug-coated balloon angioplasty for lower extremity peripheral artery diseases
J Wang, X Chen, J Zhao, WW Zhang - Annals of Vascular Surgery, 2022 - Elsevier
Background Recent evidence raised the concern that paclitaxel-containing therapy was
associated with an increased risk of mortality in patients with peripheral artery diseases …
associated with an increased risk of mortality in patients with peripheral artery diseases …